Long-Term Follow-Up of Patients After Endoscopic Sphincterotomy for Choledocholithiasis, and Risk Factors for Recurrence

Endoscopy ◽  
2002 ◽  
Vol 34 (4) ◽  
pp. 273-279 ◽  
Author(s):  
G. Costamagna ◽  
A. Tringali ◽  
S. K. Shah ◽  
M. Mutignani ◽  
G. Zuccalà ◽  
...  
Keyword(s):  
Risk Factors ◽  
Endoscopic Sphincterotomy ◽  
Long Term Follow Up ◽  
Risk Factors For Recurrence

Percutaneous trans-hepatic cholangioscopic treatment for hepatolithiasis: Long-term follow-up results and risk factors for recurrence

2000 ◽  
Vol 118 (4) ◽  
pp. A5
Author(s):  
Eun Taek Park ◽  
Myung Hwan Kim ◽  
Sung Koo Lee ◽  
Seung Jae Myung ◽  
Dong Wan Seo ◽  
...  
Keyword(s):  
Risk Factors ◽  
Long Term Follow Up ◽  
Risk Factors For Recurrence

Postoperative UFT Adjuvant and the Risk Factors for Recurrence in Renal Cell Carcinoma: A Long-Term Follow-Up Study

1997 ◽  
Vol 4 (1) ◽  
pp. 8-12 ◽  
Author(s):  
Seiji Naito ◽  
Joichi Kumazawa ◽  
Tetsuo Omoto ◽  
Atsushi Iguchi ◽  
Kazuyuki Sagiyama ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
Risk Factors For Recurrence

Extension of anticoagulation after venous thromboembolism

2008 ◽  
Vol 28 (03) ◽  
pp. 110-119 ◽  
Author(s):  
S. Schulman
Keyword(s):  
Risk Factors ◽  
Venous Thromboembolism ◽  
Secondary Prophylaxis ◽  
Factors Associated ◽  
Long Term Follow Up ◽  
Risk Factors For Recurrence ◽  
Individual Decisions ◽  
The Individual

SummaryWhereas every clinician agrees on the need for anticoagulation initially after the diagnosis of venous thromboembolism (VTE), the opinions regarding optimal duration of secondary prophylaxis differ. The decision is complicated by the large number of identified risk factors associated with the risk of recurrence. In addition consideration has to be taken to the risk factors for bleeding and individual patient preferences. Data from long-term follow-up studies up to a decade indicate that some risk factors for recurrence decline and others seem to gain importance with time. In this review data has been extracted from the most illustrative trials to highlight controversies but also where there is consensus in order to give the clinician some support for the individual decisions on extension of anticoagulation after VTE.

scholarly journals Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up

2021 ◽  
Vol 4 (3) ◽  
pp. 81-86
Author(s):  
Erdem Eren ◽  
◽  
Akif Islek ◽  
Uygar Levent Demir ◽  
Sercan Gozde ◽  
...  
Keyword(s):  
Risk Factors ◽  
Retrospective Study ◽  
Long Term Follow Up ◽  
Risk Factors For Recurrence

scholarly journals Endoscopic papillectomy; a retrospective international multicenter cohort study with long-term follow-up

2020 ◽  
Author(s):  
Jeska A. Fritzsche ◽  
Amir Klein ◽  
Maarten J. Beekman ◽  
Jeanin E. van Hooft ◽  
Mayenaaz Sidhu ◽  
...  
Keyword(s):  
Risk Factors ◽  
Adverse Events ◽  
Significant Proportion ◽  
Malignant Degeneration ◽  
Time To Recurrence ◽  
Endoscopic Papillectomy ◽  
Long Term Follow Up ◽  
Risk Factors For Recurrence

Abstract Background Endoscopic papillectomy (EP) is considered a relatively safe and minimally invasive treatment for papillary adenomas. In the literature a significant risk for local recurrence is described. The aim of this study was to evaluate long-term recurrence rates and time-to-recurrence. Additionally, risk factors for recurrence, malignancy and adverse events were studied. Methods This is a retrospective study in consecutive patients with papillary adenomas who underwent EP in two tertiary referral hospitals between 2001 and 2018. Primary outcome was recurrence in patients with at least 1-year endoscopic follow-up. Secondary outcomes were surgery free survival, adverse events, and mortality within 30 days after the index procedure. Results A total of 259 patients were found eligible [median age 66 years, 130 male (50.2%)]. Forty-three patients were known with familial adenomatous polyposis (FAP) (16.6%). At least 1-year endoscopic follow-up was available in 154 patients with a total follow-up of 586 person-years and median of 40 months [interquartile range (IQR) 25–75]. Recurrence occurred in 24 cases (15.6%) of which 8 were known with FAP, leading to a recurrence incidence rate of 4.1 per 100 person-years with a median time-to-recurrence of 29 months (IQR 14.75–59.5). Fifty-three patients underwent at least 5-year follow-up, in 6 (11.3%) of them recurrence was encountered after 5 years of which four were known with FAP. No risk factors for recurrence could be identified. Adverse events occurred in 50/259 patients (19.3%). One patient died within 30 days after the procedure. Papillary stenosis occurred in 19/259 (7.3%) of the patients. There were no cases of malignant degeneration during follow-up. Conclusions Recurrence after EP occurs in a significant proportion of patients and occurs even 5 years after EP. This emphasizes the need for long-term follow-up. We advise to consider at least 5-year follow-up in case of a sporadic adenoma, unless comorbidity makes follow-up clinically irrelevant.

Sign in / Sign up

Export Citation Format

Share Document